About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Notice of 2015 Annual General Meeting
April 22, 2015
Click here to read more
Post navigation
Previous Post
Appendix 3X Notices – Three New Directors
Next Post
2014 Annual Report
Related Posts
Phosphagenics Director and Founder Steps Down
July 9, 2015
Receipt of R&D Tax Incentive
November 27, 2018
Avecho’s Phase III Clinical Trial for Insomnia Commences
March 26, 2024
March 26, 2024